September 22, 2011
3:11-cv-02214
35:271 Patent Infringement
News Coverage, Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
A California federal judge on Wednesday refused to let Santaris Pharma A/S Corp. off the hook in Isis Pharmaceuticals Inc.'s infringement suit accusing its competitor of leveraging Isis' patented gapmer antisense drug development platform to sign multimillion-dollar deals with industry giants.